First batch of medication was released in the new sachet formulation

Lab staff

November 2020 saw the release of the first batch of medication in the new sachet formulation. This has been possible thanks to the collaboration between PCI and Pharmex with the participation of Medalchemy for the production of API (active pharmaceutical ingredient) and not only represents a milestone in achieving one of the objectives of the CLINGLIO project but will also contribute to improving the quality of life of the patients in our clinical trial and reducing the climate impact of the production and distribution of the medicine.